Executive Director, Commercial Data Strategy and Analytics at Acadia Pharmaceuticals

Conshohocken, Pennsylvania, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalsIndustries

Skills

Key technologies and capabilities for this role

Data StrategyAnalyticsAIData SciencePredictive AnalyticsCRMSpecialty Pharmacy DataClaims DataEMR DataCommercial Data ManagementLeadership

Questions & Answers

Common questions about this position

What is the employment type for this position?

This is a full-time position.

What are the key responsibilities of the Executive Director role?

The role involves defining and leading a multi-year commercial data and analytics vision, owning the global commercial data strategy, supporting advanced analytics and automation, and overseeing delivery of integrated insights across global and U.S. markets.

What teams will this role oversee?

The role includes oversight of the commercial analytics team, commercial data management team, and cross-functional insight generation across U.S. and ex-U.S. markets.

What skills or experience are needed for this position?

The role requires expertise in commercial data strategy, advanced analytics including AI and predictive analytics, data governance, BI dashboard development, and leading commercial insights across global markets.

What is the company's focus and main product?

Madrigal is a biopharmaceutical company pursuing novel therapeutics for NASH/MASH, with their first therapy Rezdiffra (resmetirom) granted accelerated FDA approval for adults with NASH and moderate to advanced liver fibrosis.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees